About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: October 13, 2008
FDA Announces a Drug Approval with a Press Release
On Friday, October 10, the FDA issued a press release about a new product approval. The approval is called Rapaflo (silodosin) capsules and it is indicated for the treatment of symptoms due to benign prostatic hyperplasia (BPH), a condition also … Continue reading
Posted in FDA Policy
1 Comment